The 5 linked references in paper A. Chernysh M., E. Kozlova K., V. Moroz V., V. Sergunova A., O. Gudkova E., E. Manchenko A., A. Kozlov P., А. Черныш М., Е. Козлова К., В. Мороз В., В. Сергунова А., О. Гудкова Е., Е. Манченко А., А. Козлов П. (2018) “Влияние антиоксиданта на основе янтарной кислоты на превращение метгемоглобина в оксигемоглобин in vitro // Effects of Succinate-Based Antioxidant on in vitro Conversion of Methemoglobin in Oxyhemoglobin” / spz:neicon:reanimatology:y:2018:i:2:p:46-59

  1. Bradberry S.M. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicol. Rev.2003; 22 (1): 13-27. DOI: 10.2165/00139709-200322010-00003. PMID: 14579544
  2. Kohn M.C., Melnick R.L., Ye F., Portier C.J.Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat. Drug. Metab. Dispos. 2002; 30 (6): 676–683. DOI: 10.1124/dmd.30.6.676. PMID: 12019195
  3. Lee J., El-Abaddi N., Duke A., Cerussi A.E., Brenner M., Tromberg B.J. Noninvasive in vivomonitoring of methemoglobin formation and reduction with broadband diffuse optical spectroscopy. J. Appl. Physiol. 2006; 100 (2): 615–622. DOI: 10.1152/japplphysiol.00424.2004. PMID: 16223982
  4. Greenberg M.I. Methylene Blue: fast-acting antidote for methemoglobinemia. Emerg. Med. News.2001; 23 (9): 26. DOI: 10.1097/01.EEM. 0000292322.94148.37
  5. Skold A., Cosco D.L., Klein R.Methemoglobinemia: pathogenesis, diagnosis, and management. South Med. J.2011; 104 (11): 757–761. DOI: 10.1097/SMJ.0b013e318232139f. PMID: 22024786